Cancer invasion and anaerobic bacteria: new insights into mechanisms
- PMID: 38535967
- PMCID: PMC10995961
- DOI: 10.1099/jmm.0.001817
Cancer invasion and anaerobic bacteria: new insights into mechanisms
Abstract
There is growing evidence that altered microbiota abundance of a range of specific anaerobic bacteria are associated with cancer, including Peptoniphilus spp., Porphyromonas spp., Fusobacterium spp., Fenollaria spp., Prevotella spp., Sneathia spp., Veillonella spp. and Anaerococcus spp. linked to multiple cancer types. In this review we explore these pathogenic associations. The mechanisms by which bacteria are known or predicted to interact with human cells are reviewed and we present an overview of the interlinked mechanisms and hypotheses of how multiple intracellular anaerobic bacterial pathogens may act together to cause host cell and tissue microenvironment changes associated with carcinogenesis and cancer cell invasion. These include combined effects on changes in cell signalling, DNA damage, cellular metabolism and immune evasion. Strategies for early detection and eradication of anaerobic cancer-associated bacterial pathogens that may prevent cancer progression are proposed.
Keywords: aggressive cancer; anaerobic bacteria; bacterial invasion; cancer; infection; intracellular bacteria; mechanisms; metastases; pathogenic; polymicrobial.
Conflict of interest statement
Rachel Hurst, Daniel S. Brewer, Abraham Gihawi, John Wain and Colin S. Cooper are coinventors on a patent application (UK Patent Application No. 2200682.9) from the University of East Anglia/UEA Enterprises Limited regarding the application of the anaerobic bacteria biomarkers set (ABBS) genera in prostate cancer.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
